key: cord-0853354-6jbm4rr2 authors: Chi, Hsin; Chiu, Nan-Chang; Tai, Yu-Lin; Chang, Hung-Yang; Lin, Chao-Hsu; Sung, Yi-Hsiang; Tseng, Cheng-Yin; Yu-Min Liu, Lawrence; Lin, Chien-Yu title: Clinical features of neonates born to mothers with coronavirus disease-2019: a systematic review of 105 neonates date: 2020-08-14 journal: Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi DOI: 10.1016/j.jmii.2020.07.024 sha: 79480d022d16a58615c789081b16fad58478badc doc_id: 853354 cord_uid: 6jbm4rr2 Abstract Background Despite the increasingly recognized impact of novel coronavirus disease (COVID-19), caused by severe acute respiratory syndrome (SARS) coronavirus 2 (SARS-CoV-2), on many aspects of health in adults and children, its effects on neonates born to infected mothers remain unclear. We conducted this study to investigate the outcomes of neonates born to mothers with COVID-19. Methods We searched the medical databases from inception to March 31, 2020 to perform a systematic review of outcomes in neonates born to mothers with COVID-19. Data were pooled using a random effects regression model. Primary and secondary outcomes were neonatal clinical outcomes and infectious status, respectively. Results Fourteen studies involving 105 neonates fulfilling the study criteria were identified. The rates of preterm neonates and those small for gestational age (SGA) were 25 (23.8%) and 10 (11.2%), respectively. Among 91 neonates who were tested, 8 (8.8%) were positive for nucleic acids or antibodies for SARS-CoV-2. Additionally, 28 (26.7%) of the neonates were symptomatic and two test-negative neonates died, including one stillbirth. Between test-positive and test-negative groups, the rates of SGA, preterm delivery, duration between maternal symptom onset and delivery, and perinatal complication were not significantly different; but the rate of symptomatic after birth reached significant difference (62.5% vs 20.5%, p=0.008). Conclusions Most neonates born to infected mothers had favorable outcomes. Although direct evidences of intrauterine infection were scarce, the risk of intrauterine infection should be considered based on a positive test in 8.8% of the neonates. Symptomatic neonates born to infected mothers should receive tests for SARS-CoV-2 to initiate appropriate treatment and quarantine. Further studies are warranted to assess the outcomes of COVID-19 in neonates. (COVID- 19) , caused by severe acute respiratory syndrome (SARS) 10 coronavirus 2 (SARS-CoV-2), on many aspects of health in adults and 11 children, its effects on neonates born to infected mothers remain unclear. 12 We conducted this study to investigate the outcomes of neonates born to 13 mothers with COVID-19. 14 15 Fourteen studies involving 105 neonates fulfilling the study criteria were 24 identified. The rates of preterm neonates and those small for gestational 25 age (SGA) were 25 (23.8%) and 10 (11.2%), respectively. Among 91 26 neonates who were tested, 8 (8.8%) were positive for nucleic acids or 27 antibodies for SARS-CoV-2. Additionally, 28 (26.7%) of the neonates 28 were symptomatic and two test-negative neonates died, including one 29 stillbirth. Between test-positive and test-negative groups, the rates of SGA, 30 preterm delivery, duration between maternal symptom onset and delivery, 31 and perinatal complication were not significantly different; but the rate of 32 symptomatic after birth reached significant difference The rate of 33 symptomatic neonates was higher among the test-positive neonates 34 compared with the test-negative neonates (62.5% vs 20.5%, p=0.008). Coronavirus disease-2019 (COVID-19) caused by severe acute 53 respiratory syndrome (SARS) coronavirus 2 (SARS-CoV-2) is an 54 emerging disease with a massive disease burden. [1] [2] [3] [4] The main 55 manifestations of COVID- 19 Studies investigating "pregnancy," "pregnant," "mother," "neonates," 102 "infant," or "children" were analyzed. Exclusion criteria were duplicate multiple organ failure, extracorporeal membrane oxygenation use, or 115 mortality. In case of a disagreement between two authors, consensus was 116 reached through discussion with the third author. The quality assessment 117 were conducted independently by two authors based on the domains of 118 selection, ascertainment, causality and reporting. 12 119 120 Statistical Analyses 121 If continuous outcomes were assessed, data were analyzed using odds 122 ratios with 95% confidence intervals. For categorized variables, 123 comparison was performed using Student's t test and the chi-square test. If 124 meta-analysis was performed, we used a random-effects regression model 125 assuming that the true effect size was not the same. 13 Heterogeneity was 126 further quantified using the Cochran Q test and I 2 statistics. 14 A p value less 127 than 0.05 was regarded as statistically significant. Review Manager v5.3.5 128 (Cochrane Community, London, UK) and SPSS version 23.0 (SPSS, 129 Chicago, IL, USA) were used for statistical analyses. 8 The search process is illustrated in Figure 1 neonates are valuable to draw a definite conclusion. 263 We found that 26.7% of the neonates born to mothers with COVID-19 264 were symptomatic after birth and that most of the symptoms were mild. Severe acute respiratory syndrome coronavirus 2 327 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges Emerging threats from zoonotic coronaviruses-from SARS and MERS to 330 2019-nCoV Are children less susceptible to COVID-19? COVID-19: Taiwan's epidemiological 334 characteristics and public and hospital responses Clinical Characteristics of Coronavirus 336 Disease 2019 in China COVID-19) Outbreak in China: Summary of a Report of 72314 Cases From the Chinese 339 Center for Disease Control and Prevention Coronavirus disease (COVID-19) outbreak situation 2020 Preferred reporting items 352 for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and 353 explanation Methodological quality and synthesis of case series 355 and case reports Meta-analysis in clinical trials Quantifying heterogeneity in a meta-analysis Clinical characteristics and intrauterine 360 vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective 361 review of medical records Possible Vertical Transmission of SARS-CoV-2 366 From an Infected Mother to Her Newborn Perinatal Transmission of COVID-19 Associated 368 SARS-CoV-2: Should We Worry? Lack of Vertical Transmission of Severe 371 Acute Respiratory Syndrome Coronavirus 2 Clinical manifestations and outcome of SARS-CoV-2 infection 373 during pregnancy A case report of neonatal COVID-19 infection 376 in China Clinical analysis of pregnant women with 2019 novel 391 coronavirus pneumonia Pregnancy and perinatal outcomes 394 of women with severe acute respiratory syndrome H1N1 396 2009 influenza virus infection during pregnancy in the USA ACE2 expression and activity are 398 enhanced during pregnancy ACE2 receptor polymorphism: Susceptibility to SARS-CoV-2, 400 hypertension, multi-organ failure, and COVID-19 disease outcome Association between 403 preterm birth and the renin-angiotensin system in adolescence: influence of sex and obesity Clinical features of patients infected with 2019 406 novel coronavirus in Wuhan, China # Days referred to duration between maternal symptom onset and delivery; a negative day meant symptom onset after delivery ## Neonatal symptoms included fever, tachypnea, shortness of breath, and vomiting